Inogen, Inc. (INGN) Stock

Inogen, Inc. (INGN) is a Healthcare stock trading at $6.41 (as of 2026-06-18), with a market capitalization of $175.71M and a trailing P/E of -7.0. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Inogen, Inc. designs, manufactures, and sells portable and home oxygen therapy devices, including portable oxygen concentrators, stationary concentrators, and ventilator systems with related accessories. Its products are used for long-term supplemental oxygen therapy for patients with chronic respiratory conditions and are marketed to patients, clinicians, and third-party payors in the U.S. and internationally.

Valuation — source: SEC EDGAR (first-party)
Price	$6.41
Market Cap	$175.71M
P/E Ratio	-7.0
EV / EBITDA	-6.9
Price / Book	0.95
Price / Sales	0.49
DCF Value (model)	$-4.73
DCF Upside vs Price	-173.8%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$348.67M
Net Margin	-6.5%
Return on Equity	-13.6%
Current Ratio	3.10
Revenue Growth (YoY)	3.4%
EPS Growth (YoY)	20.0%
FCF Growth (YoY)	-59.6%

Financial Health — source: SEC EDGAR
Altman Z-Score	1.54 (distress)

Valuation vs Sector & Industry
Stock P/E	-7.0
Sector P/E (Healthcare)	21.0
Industry P/E (Medical Equipment)	31.7
vs Sector	-133.6%
vs Industry	-122.2%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	BlackRock Fund Advisors ($87.74M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	Kevin R. Smith
Employees	766
Country	US
IPO Date	2014-02-14

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.